Eterna Therapeutics
ERNA
#10531
Rank
C$7.85 M
Marketcap
C$0.27
Share price
-0.10%
Change (1 day)
-93.83%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): C-$103.97

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is C-$106.09. In 2022 the company made an earnings per share (EPS) of C-$174.04 an increase over its 2021 EPS that were of C-$1,150.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$103.97
2022C-$174.04-84.86%
2021C-$1,150

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
C$2.86-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
C-$2.56-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
C-$2.79-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.17-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
C$1.71-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
C$0.72-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA